Patents for C07F - Acyclic, carbocyclic, or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium (663) |
---|
09/30/2004 | WO2004082604A2 Phosphoric ester demulsifier composition |
09/28/2004 | US6797182 To remove oxygen and water; for semiconductors |
09/16/2004 | US20040180969 Phosphoric ester demulsifier composition |
09/16/2004 | US20040180947 Sulfonamide compounds and pharmaceutical use thereof |
09/14/2004 | US6790957 Converting tertiary hydroxy group of a triazole antifungal compound into a phosphate group to improve aqueous solubility |
09/10/2004 | WO2004076465A2 Silyl acrylate and poss compositions used in microlithographic processes |
09/09/2004 | US20040176615 Forming calcium salt from ester |
09/09/2004 | US20040176327 Use of bisphosphonic acids for treating angiogenesis |
08/31/2004 | US6784169 Metalloprotease inhibitor; antiinflamamtory agents; rheumatic disorders; cardiovascular disorders; controlling cell proliferation |
08/17/2004 | US6777552 From an ester derivative or protected ester derivative of the statin by using calcium hydroxide |
08/10/2004 | US6774121 Phospholipid prodrugs of anti-proliferative drugs |
08/05/2004 | WO2004065396A2 Phosphoric esters of polyisobutene-substituted aromatic hydroxy compounds |
07/29/2004 | DE10302626A1 New polybutylphenyl phosphate esters, used e.g. as surface modifier, corrosion inhibitor, dispersant or adhesion promoter, are prepared by corresponding phenol with phosphorus oxyhalide and optionally water, alcohol, thiol or amine |
07/21/2004 | EP1438965A1 Use of extracts from Hoodia gordonii and Hoodia lugardii for the preparation of a medicament for use in the suppression of appetite |
07/14/2004 | EP1169326B1 Process for preparing alendronic acid |
07/13/2004 | US6762317 Method for preparing formylphosphonic acid |
07/01/2004 | US20040127363 Pesticidal compositions containing silicon compounds |
06/24/2004 | WO2003090690A3 Cellular accumulation of phosphonate analogs of hiv protease inhibitor compounds and the compounds as such |
06/24/2004 | US20040121316 Method and compositions for identifying anti-HIV therapeutic compounds |
06/17/2004 | US20040112375 Predicting outcome of hyperbaric oxygen therapy treatment with nitric oxide bioavailability |
06/03/2004 | WO2004046155A2 Predicting outcome of hyperbaric oxygen therapy treatment with nitric oxide bioavailability |
05/19/2004 | EP0781136B1 Compounds and methods for the treatment of cancer |
03/31/2004 | CN1143668C Ascorbyl-phosphoryl-cholesterol |
03/16/2004 | US6706896 Process for selective derivatization of taxanes |
03/11/2004 | WO2003091264A3 Non nucleoside reverse transcriptase inhibitors |
03/11/2004 | DE10334820A1 Pharmazeutische Zusammensetzungen mit antibiotischer Aktivität Pharmaceutical compositions having antibiotic activity |
03/03/2004 | CN1140531C Method for manufacturing phosphine compound |
02/24/2004 | US6696601 Bone disorders |
02/18/2004 | EP0918781B1 Asymmetric synthesis catalyzed by transition metal complexes with cyclic chiral phosphine ligands |
02/11/2004 | EP1003754B1 Method of manufacturing phosphine compound |
02/05/2004 | US20040022866 Use of sodium and potassium salts of citric, phosphoric, carbonic and tartaric acid and arginine and lysine as stabilizer of the antibiotic Fosfomycin Tromethamine |
01/27/2004 | US6683079 Reverse transcriptase inhibitors |
12/17/2003 | EP1370142A2 Pesticidal compositions containing silicon compounds |
12/17/2003 | EP1283842B1 Radiopharmaceutical products suitable for the selective labeling of lymphocytes, and their preparation |
11/27/2003 | US20030220303 GABAB Receptor Agonists; used to treat gastrointestinal disorders, especially GERD |
11/19/2003 | EP1235832B1 Vitamin d prescursors, method and intermediates |
11/06/2003 | WO2003091264A2 Non nucleoside reverse transcriptase inhibitors |
11/06/2003 | WO2003090691A2 Method and compositions for identifying anti-hiv therapeutic compounds |
11/06/2003 | WO2003090690A2 Cellular accumulation of phosphonate analogs of hiv protease inhibitor compounds and the compounds as such |
11/06/2003 | CA2481449A1 Method and compositions for identifying anti-hiv therapeutic compounds |
11/06/2003 | CA2481285A1 Non nucleoside reverse transcriptase inhibitors |
11/05/2003 | CN1126755C Process for preparing N-[5-(diphenyl phosphinyl methyl)-4-(4-fluoropheyl)-6-isopropyl pyrimidine-2-group]-N-methl methane sulfamide |
10/28/2003 | US6638956 Pesticidal 1-arylpyrazoles |
10/21/2003 | CA2098020C Anti-viral compounds |
10/15/2003 | CN1448142A Compositions comprising cytosine derivatives for the treatment of cancer |
10/09/2003 | US20030191092 MMP inhibitors |
09/09/2003 | US6617339 Oxazolidinone derivatives, process for their preparation and pharmaceutical compositions containing them |
07/31/2003 | US20030144263 Oxazolidinone derivatives, process for their preparation and pharmaceutical compositions containing them |
07/31/2003 | US20030144251 Pesticidal 1-arylpyrazoles |
07/31/2003 | US20030144250 Triazole derivatives useful in therapy |
07/24/2003 | WO2003059921A1 Mmp inhibitors |
07/24/2003 | CA2470649A1 Mmp inhibitors |
07/03/2003 | US20030125340 3-(Amino-or aminoalkyl) pyridinone derivatives and their use for the treatment of HIV related diseases |
06/19/2003 | US20030114706 Aminomethylphosphonic acid is contacted with water, an alcohol, a phenol and an oxidizing gas in the presence of a catalyst |
06/19/2003 | US20030114685 Processes for preparing calcium salt forms of statins |
06/18/2003 | CN1425078A Process for purification of organometallic compounds or heteroato mic organic compounds with a catalyst based on iron and manganese supported on zeolites |
06/18/2003 | CN1425077A Process for purification of organometallic compounds or heteroatomic getter alloys |
06/18/2003 | CN1425019A Vitamin D Precursors, preparation and intermediates thereof |
06/18/2003 | CN1111409C Use of cytosine in preparation of medicines for treatment of cancers |
06/10/2003 | US6576626 Treating gastro-oesophageal reflux disease |
06/03/2003 | US6573401 Reacting 4-aminobutyric acid with a phosphonation mixture of phosphorous acid and methanesulfonic anhydride, hydrolyzing the resulting reaction product, isolation by an appropriate pH adjustment, free acid or monosodium salt |
05/28/2003 | EP1313748A1 Compositions comprising dimeric or oligomeric ferrocenes |
05/08/2003 | US20030086984 Treating collected plant material with a solvent to extract a fraction having appetite suppressant activity, separating extraction solution from plant material, removing the solvent from extraction solution and recovering |
04/23/2003 | EP1205484B1 Process for producing 4-amino-1-hidroxybutylidene-1,1-bisphosphonic acid and its trihydrated monosodic salt |
04/09/2003 | CN1409716A New amino propylphosphinic acid |
04/03/2003 | US20030065214 Novel hydrate forms of alendronate sodium, processes for manufacture thereof, and pharmaceutical compositions thereof |
03/26/2003 | CN1103778C Compound containing alkoxyl silicane group and nexyl-inner-ureide group |
03/05/2003 | EP0744396B1 Novel complex salts of phosphoric and amino acids and ruminant feed additive composition containing the same |
02/27/2003 | US20030038082 Process for the purification of organometallic compounds or heteroatomic organic compounds with hydrogenated getter alloys |
02/19/2003 | EP1283842A1 Radiopharmaceutical products suitable for the selective labeling of lymphocytes, and their preparation |
02/11/2003 | US6518428 The present invention relates to the area of platinum drugs. In particular, it relates to an improved process for preparing platinum complexes having the general formula (Ia) or (Ib): as defined of herein, |
01/15/2003 | EP1274879A1 A process for the purification of organometallic compounds or heteroatomic organic compounds with hydrogenated getter alloys |
01/14/2003 | CA2288760C Ascorbyl-phosphoryl-cholesterol |
01/09/2003 | US20030009046 Preparation of preparing substituted indanones |
01/02/2003 | US20030003147 Effer-vescent bisphosphonate formulation |
12/31/2002 | US6500850 Pesticidal 1-arylpyrazoles |
12/11/2002 | CN1384749A Use of diphophonic acid in treatment of vasculogenesis |
12/10/2002 | US6492539 Preparation of preparing substituted indanones |
11/14/2002 | US20020168427 Plant extract |
10/24/2002 | US20020156053 Treating gastro-oesophageal reflux disease |
10/22/2002 | US6469146 Radiopharmaceutical products suitable for the selective labeling of lymphocytes, and their preparation |
10/03/2002 | US20020142996 Use of bisphosphonic acids for treating angiogenesis |
09/18/2002 | EP1240172A1 New aminopropylphosphinic acids |
09/17/2002 | US6451822 3-(Amino- or aminoalkyl)pyridinone derivatives and their use for the treatment of HIV related diseases |
09/11/2002 | EP0912583B1 Ligands for asymmetric catalysis |
09/04/2002 | EP1235832A1 Vitamin d prescursors, method and intermediates |
07/25/2002 | US20020099212 Sulfonamide compounds and pharmaceutical use thereof |
07/17/2002 | EP1222927A2 Pharmaceutical compositions having appetite suppressant activity |
07/03/2002 | EP1218013A2 Phospholipid prodrugs of anti-proliferative drugs |
06/19/2002 | EP0980354B1 Vitamin d3 analogs with bis c-20 side chains |
06/13/2002 | WO2001067863A3 Pesticidal compositions containing silicon compounds |
06/12/2002 | EP1213020A2 Pharmaceutical compositions having appetite suppressant activity |
06/12/2002 | EP0880533B1 Triazole derivatives useful in therapy |
06/11/2002 | CA2240777C Triazole derivatives useful in therapy |
05/22/2002 | EP1169326A4 Process for preparing alendronic acid |
05/22/2002 | CN1350540A Process for preparing amine platinum complexes |
05/22/2002 | CN1085213C Triazole derivatives useful in therapy |
05/15/2002 | EP1205484A1 Process for producing 4-amino-1-hidroxybutylidene-1,1-bisphosphonic acid and its trihydrated monosodic salt |
05/02/2002 | US20020052527 Novel process for preparing alendronic acid |
04/23/2002 | US6376657 Pharmaceutical compositions having appetite suppressant activity |